Author: Ravi Shankar

Engages U.S.-Based Contract Manufacturer, Targeting Initial Domestic Production by Year-End

Expands Production Capacity and Supports Alignment with Evolving U.S. Federal Procurement and NDAA Requirements

Palo Alto, California, Nov. 12, 2026 (GLOBE NEWSWIRE) — Mobilicom Limited (Nasdaq: MOB) (“Mobilicom” or the “Company”), a provider of cybersecure solutions for drones and robotics, today announced that it has engaged a U.S.-based contract manufacturer with extensive experience supporting the stringent requirements of the defense and aerospace industries, as part of its strategy to expand and onshore production of its proprietary cybersecure datalink product family. The milestone marks the establishment of Mobilicom’s first U.S. manufacturing operations in Phoenix, Arizona, with initial domestically manufactured products currently expected by the end of 2026.

“We are proud to deliver on our 2026 strategic initiative to establish U.S.-based manufacturing operations,” said Oren Elkayam, CEO of Mobilicom. “Our technologies have been trusted, validated and deployed across U.S. defense programs. Expanding our manufacturing footprint into the U.S. is the next step in scaling production to meet growing customer demand, shorten delivery lead times and enhance supply chain resilience. With our first U.S.-manufactured products expected by year-end, we believe Mobilicom will be well-positioned to support larger-scale deployments and capture additional market share in 2027 and beyond.”

Mobilicom’s expansion into U.S. manufacturing builds on its established presence in the U.S. defense market, including the integration of its technologies into a Tier-1 drone platform selected for a U.S. Department of War Program of Record. The Company’s cybersecure solutions are NDAA-compliant and have been included in the FCC’s initial Trusted Drones exemptions and the Department of War’s Blue UAS Framework, reinforcing its position as a trusted supplier of mission-critical technologies for U.S. defense applications.

About Mobilicom

Mobilicom is a leading provider of cybersecure robust solutions for the rapidly growing defense and commercial drones and robotics market. Mobilicom’s large portfolio of field-proven technologies includes cybersecurity, software, hardware, and professional services that power, connect, guide, and secure drones and robotics. Through deployments across the globe with over 50 customers, including the world’s largest drone manufacturers, Mobilicom’s end-to-end solutions are used in mission-critical functions.

For investors, please use https://ir.mobilicom.com/  
For company, please use www.mobilicom.com

Forward Looking Statements

This press release contains “forward-looking statements” that are subject to substantial risks and uncertainties. For example, the Company is using forward-looking statements when it discusses its expectation to establish U.S. manufacturing operations through a U.S.-based contract manufacturer; the anticipated timing of initial domestically manufactured products, including by the end of 2026; the expected benefits of U.S. manufacturing, including increased production capacity, shorter delivery lead times and enhanced supply chain resilience; anticipated alignment with U.S. federal procurement and NDAA requirements; growing customer demand; and the Company’s ability to support larger-scale deployments and gain additional market share in 2027 and beyond. All statements, other than statements of historical fact, contained in this press release are forward-looking statements. Forward-looking statements contained in this press release may be identified by the use of words such as “anticipate,” “believe,” “contemplate,” “could,” “estimate,” “expect,” “intend,” “seek,” “may,” “might,” “plan,” “potential,” “predict,” “project,” “target,” “aim,” “should,” “will” “would,” or the negative of these words or other similar expressions, although not all forward-looking statements contain these words. Forward-looking statements are based on Mobilicom Limited’s current expectations and are subject to inherent uncertainties, risks and assumptions that are difficult to predict. Further, certain forward-looking statements are based on assumptions as to future events that may not prove to be accurate. These and other risks and uncertainties are described more fully in the Company’s filings with the Securities and Exchange Commission.

Forward-looking statements contained in this announcement are made as of this date, and Mobilicom Limited undertakes no duty to update such information except as required under applicable law.

For more information on Mobilicom, please contact:

Chris Donovan
Mobilicom Ltd
ir@mobilicom.com

Vancouver, British Columbia, Nov. 12, 2026 (GLOBE NEWSWIRE) — NevGold Corp. (“NevGold” or the “Company”) (TSXV:NAU) (OTCQX:NAUFF) (Frankfurt:5E50) is pleased to announce additional oxide gold-antimony assays from the 2026 drill program at its Limousine Butte Project (the “Project”, “Limo Butte”) in Nevada. These results have continued to extend high-grade mineralization on the eastern side of the Resurrection Ridge resource, adding significant mineralization potential both inside and outside of the 2026 Mineral Resource Estimate (“MRE”) pit-shell released on July 15, 2026 (see News Release).

NevGold CEO, Brandon Bonifacio, comments: “The 2026 drill program at Limo Butte continues to deliver exceptional results, expanding mineralization beyond the boundaries of the current resource and supporting our objective of growing both the scale and quality of the 2026 MRE released in July. We are particularly encouraged by the consistency of high-grade oxide gold-antimony mineralization encountered on the eastern side of the Resurrection Ridge resource area. Hole LB26-009 was the strongest hole to date from our 2026 program intercepting grade up to 14.50 g/t oxide Au, with larger intervals of 8.28 g/t oxide Au over 3.0 meters within 1.73 g/t oxide Au over 45.7 meters. The program remains on schedule and under budget, with approximately 16,000 meters completed across 70 holes, and assays pending from 54 additional holes. The combination of exceptional results received, a substantial volume of assays still pending, and increasing confidence in our geological model reinforces our belief that Limo Butte is emerging as one of the most significant gold-antimony development projects in the United States.”

Key Highlights

• Strongest result to date from 2026 drill program; intercepts more high-grade oxide gold-antimony expanding mineralization both inside and outside of 2026 MRE pit-shell:

• • LB26-009 Lower Zone (expansion inside of 2026 pit-shell): 8.28 g/t Au over 3.0 meters within 1.73 g/t Au over 45.7 meters; highest grade drilled in 2026 with up to 14.50 g/t oxide Au
  • LB26-009 Upper Zone (expansion inside of 2026 pit-shell): 0.45% Sb over 10.7 meters within 0.18% Sb over 50.3 meters
  • LB26-017 (expansion inside and outside of 2026 pit-shell): 3.13 g/t AuEq over 12.2 meters (1.19 g/t Au, 0.50% Sb) within 1.27 g/t AuEq over 48.8 meters (0.37 g/t Au, 0.23% Sb)

• +$42 million in treasury focused on project development and growth strategy execution

• 70 holes completed, 54 holes with assays pending after this News Release

• • Approximately 16,000 meters completed of targeted 20,000 meters

• Advancing Preliminary Economic Assessment (“PEA”) Engineering Study at Limo Butte with targeted completion Q1-2027

Limo Butte Planned 2026-2027 Activities / Status Update

NevGold will continue its active work programs at Limo Butte including:

• Continuing to drill test gold-antimony targets (~20,000 meters is planned in 2026 focused on the Bullet Zone / Armory Fault discoveries and resource conversion);

• Advancing metallurgical testwork (ongoing);

• Advancing PEA Engineering Study (in process, targeted completion Q1-2027);

• Commencing early permitting for future operations (in process; key driver of permitting is advancement of Engineering Study)

Figure 1 – Resurrection Ridge resource area with completed 2026 drilling. Figure includes outline of 2026 AuEq. resource pit-shell, priority expansion area for ongoing 2026 drilling, and intercepts for completed 2026 drilling. Ongoing road and pad construction efforts are also shown, highlighting focused efforts to expand Au and Sb mineralization to the east under the dolomite thrust. To view image please click here

Figure 2 – Section with Au values from 2026 MRE block model and Au intercepts from all drilling along section completed by NevGold in 2025-2026 drill programs. The 2026 drill program has expanded oxide gold-antimony mineralization both inside and outside of the recently announced 2026 MRE pit-shell. Figure also highlights pre-2025 drilling to the west, and NevGold 2025-2026 drilling focus to the east. To view image please click here

2026 Drilling Results – Resurrection Ridge

Hole ID	Length, m*	g/t Au***	% Sb***	g/t AuEq**	From, m	To, m
LB26-009 Upper	50.3	–	0.18%	–	7.6	57.9
including	10.7	–	0.45%	–	36.6	47.2
also including	3.0	–	1.19%	–	42.7	45.7
LB26-009 Lower	82.3	1.04	0.06%	1.26	167.6	249.9
including	45.7	1.73	0.07%	2.02	178.3	224.0
also including	3.0	8.28	0.06%	8.50	214.9	217.9
also including	1.5	14.50	0.08%	14.82	214.9	216.4
LB26-017	76.2	0.27	0.17%	0.92	16.8	100.6
including	48.8	0.37	0.23%	1.27	44.2	100.6
also including	12.2	1.19	0.50%	3.13	45.7	57.9
LB26-019	105.2	0.19	0.05%	0.39	48.8	153.9
including	15.2	0.31	–	0.31	48.8	64.0
also including	6.1	0.20	0.29%	1.33	103.6	109.7
LB26-025	9.1	–	0.22%	–	89.9	99.1
LB26-025	10.7	0.27	–	0.27	106.7	117.3

*Downhole thickness reported; true width varies depending on drill hole dip and is approximately 70% to 90% of downhole thickness.
**The gold equivalents (“AuEq”) are based on assumed metals prices of US$3,000/oz of gold and US$40,000 per tonne of antimony, and assumed metals recoveries of 80% for gold and 75% for antimony.
***Values less than 0.10 g/t Au and 0.05% Sb not included.

Drillhole Orientation Details

Hole ID	Target Zone	Easting	Northing	Elevation (m)	Length (m)	Azimuth	Dip
LB26-009	RR	667173	4417250	2189	288	210	-60
LB26-017	RR	667331	4417292	2238	229	105	-70
LB26-019	RR	667285	4417221	2252	239	110	-70
LB26-025	RR	667231	4417151	2253	244	95	-60

NevGold Geological Model Summary
The Devonian Pilot Shale (“Pilot Shale”, “Pilot”) is the principal local host to Carlin-type mineralization at Limousine Butte. At Limousine Butte, positive gold grades commonly coincide with silicification and jasperoid breccias within the Pilot Shale, and this alteration style is also host to elevated antimony.

NevGold’s 2021–2025 work included integrating historical drilling, new mapping, and surface sampling which produced an updated district model and refined property-wide controls on mineralization. At Resurrection Ridge, Devonian–Silurian dolomite is exposed immediately east of known gold-antimony mineralization. Earlier explorers inferred that the overlying Pilot Shale had been eroded in this area, and they did not test eastward, despite shallow high-grade intercepts in the easternmost holes drilled at Resurrection Ridge. The new model indicates the older dolomite was thrust over the prospective Pilot Shale unit (see Figure 5), creating structural preparation and a fluid trap that preserves the favorable host at depth, the classic architecture for a Carlin-type system.
The 2025-2026 drill programs have validated the new NevGold geological model at the Project. Holes collared in dolomite, passed through the upper thrust plate, and intersected gold and antimony at multiple horizons within the underlying Pilot Shale validating the new geological model and materially expanding the potential mineralization footprint at the Project.

The preserved Pilot Shale extends more than one kilometer east of prior drilling at Resurrection Ridge (see Figure 3 and Figure 4).

Figure 3 – Comparison of historical geological model (left) and new NevGold geological model (right) outlining the thesis that the older dolomite unit was thrust over the prospective Pilot Shale unit. The preserved Pilot Shale unit extends more than 1 kilometer east of prior drilling at Resurrection Ridge. To view image please click here

Property-wide, the updated model outlines multiple Au–Sb target corridors that track outcrops and projected subsurface positions of the Pilot Shale, where repeated faulting and thrusting provided fluid pathways and focused mineralization. NevGold’s 2026 drill program will continue to test these high-priority targets (see Figure 4).

Figure 4 – Cross section outlining the pre-2025 mineralization footprint at Resurrection Ridge, 2025 expansion area including the discovery of the Bullet Zone on the eastern side of Resurrection Ridge, and the key focus of further 2026 expansion. To view image please click here

Together, these datasets support a district-scale interpretation in which thrust repetition preserves the Pilot Shale at depth east of Resurrection Ridge and focuses Au–Sb mineralization along structurally prepared horizons, establishing multiple high-priority targets for step-out drilling and follow-up work.

Figure 5 – Limo Butte Project and identified target areas. A number of high priority targets have been defined focused on resource conversion, resource expansion, and new discoveries across the large, consolidated ~70 square kilometer (7,000 hectares) land package. NevGold maintains a continuous drill target pipeline at the Project, which will be advanced with the largest targeted drill program (~20,000 meters) that the Company has drilled since acquiring Limo Butte in 2021. To view image please click here

Figure 6 – Limousine Butte Land Holdings and District Exploration Activity To view image please click here

Investor Relations Providers
The Company wishes to clarify disclosure regarding its previous engagement of investor relations providers in its press releases dated June 3, 2025 and June 4, 2025 (collectively, the “June 2025 Press Releases”).

The June 2025 Press Releases disclosed that the Company entered into the digital marketing services agreement dated May 26, 2025 with Altura Media Co Inc. (“Altura”) in which Altura provided a comprehensive suite of investor relations services to the Company. The June 2025 Press Releases incorrectly referred to a “three-month term” when it should have referred to a “six-month term” that commenced on June 9, 2025, as provided in the digital marketing services agreement. The fees for the digital marketing services were originally priced at $145,000. The Company terminated the digital marketing services agreement with Altura prior to the end of the six-month term on September 30, 2025 and only paid a total of $100,250 to Altura under that agreement. The June 2025 Press Releases did not disclose that the Company and Altura had also entered into the consulting agreement dated May 26, 2025 in which Altura provided pre-marketing campaign consulting services to the Company for a two-week period for $5,000 that commenced on May 26, 2025. Accordingly, the total fees paid to Altura under both agreements was $105,250.

In addition, the Company engaged Machai Capital Inc. (“Machai”) to provide marketing services to the Company for a two-month term that commenced on June 1, 2025. While the June 2025 Press Releases disclosed fees of $350,000 to be paid to Machai, the parties subsequently negotiated a final fee of $661,500 for the marketing services, which had been paid in full to Machai. The Company’s initial engagement of Machai began in June, 2021 in which the Company and Machai entered into a digital marketing services agreement dated June 14, 2021. Under the digital marketing services agreement, Machai provided branding, content and data optimization to assist with the creation of marketing campaigns for the Company for a six-month term. Machai also assisted with tracking and organizing the creation of marketing campaigns through search engine optimization, search engine marketing, lead generation, digital marketing, social media marketing, email marketing and brand marketing. The Company paid Machai a fee of $3,000 per month for a total of $18,000 pursuant to the digital marketing services agreement dated June 14, 2021.

The services provided by Machai were rendered by Suneal Sandhu. The services provided by Altura were rendered by Luis Matthias Campos. The Company’s engagements with Machai and Altura are subject to the approval of the TSX Venture Exchange. See the June 2025 Press Releases for further information.

ON BEHALF OF THE BOARD
“Signed”
Brandon Bonifacio, President & CEO 

For further information, please contact Brandon Bonifacio at bbonifacio@nev-gold.com, call 604-337-4997, or visit our website at www.nev-gold.com.

Sampling Methodology, Quality Control and Quality Assurance
NevGold QA/QC protocols are followed on the Project and include insertion of duplicate, blank and standard samples in all drill holes. A 30g gold fire assay and multi-elemental analysis ICP-OES method was completed by ISO 17025 certified American Assay Labs, Reno.

Technical information contained in this news release has been reviewed and approved by Greg French, CPG, the Company’s Vice President, Exploration, who is NevGold’s Qualified Person (“QP”) under National Instrument 43-101 and responsible for technical matters of this release.

About the Company
NevGold is dedicated to discovering, de-risking, and rapidly advancing gold and critical metals projects across premier jurisdictions in Nevada and Idaho to drive shareholder value and strengthen US mineral security. The Company holds a 100% interest in the Limousine Butte (gold-antimony) and Cedar Wash (gold) projects in Nevada, and the Nutmeg Mountain (gold) and Zeus (copper) projects in Idaho. For more information, please visit www.nev-gold.com.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Note Regarding Forward Looking Statements

This news release contains forward-looking statements that are based on the Company’s current expectations and estimates. Forward-looking statements are frequently characterized by words such as “plan”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “suggest”, “indicate” and other similar words or statements that certain events or conditions “may” or “will” occur. Forward-looking statements include, but are not limited to, the proposed work programs at Limousine Butte, the exploration potential at Limousine Butte, the expansion of the  recently announced MRE at Limo Butte, and future potential project milestones such as the Preliminary Economic Assessment (“PEA”). Such forward-looking statements involve known and unknown risks, uncertainties and other factors that could cause actual events or results to differ materially from estimated or anticipated events or results implied or expressed in such forward-looking statements. Such risks include, but are not limited to, general economic, market and business conditions, and the ability to obtain all necessary regulatory approvals. There is some risk that the forward-looking statements will not prove to be accurate, that the management’s assumptions may not be correct or that actual results may differ materially from such forward-looking statements. Accordingly, readers should not place undue reliance on the forward-looking statements. Any forward-looking statement speaks only as of the date on which it is made and, except as may be required by applicable securities laws, the Company disclaims any intent or obligation to update any forward-looking statement, whether as a result of new information, future events or results or otherwise. Forward-looking statements are not guarantees of future performance and accordingly undue reliance should not be put on such statements due to the inherent uncertainty therein.

• Ticker change effective November 12, 2026, reflects the recent decision to terminate merger with Cove Kaz. 
• New ticker symbol reflects the Company’s focus on becoming a highly strategic supplier of critical minerals and nuclear fuels and will focus on prioritizing security of supply for US customers.

GRAND CAYMAN, Cayman Islands, Nov. 12, 2026 (GLOBE NEWSWIRE) — Skyline Builders Group Holding Limited (NASDAQ: CRMN) (“Skyline” or “the Company”), a holding company seeking to become a highly strategic supplier of critical minerals and nuclear fuels prioritizing the security of supply for US customers, today announced that it will change its Nasdaq ticker symbol from KAZR to CRMN, effective November 12, 2026. This ticker change was anticipated after the termination of the business combination with Cove Kaz Capital Group (“Cove Kaz”), as announced on November 2, 2026.

On November 2, 2026, Skyline and Cove Kaz mutually agreed to terminate their previously announced business combination agreement with Cove Kaz now seeking a direct listing during 1H 2027. As part of this mutual termination, Skyline agreed to change its Nasdaq ticker symbol.

The ticker change reflects the company’s focus on becoming a highly strategic supplier of critical minerals and nuclear fuels and will focus on prioritizing security of supply for US customers.

“We strongly support Cove Kaz’s proposed listing strategy. In connection with the change of our ticker symbol to “CRMN,” Skyline is preparing to expand its presence in the critical minerals sector,” said Paul Mann, executive chairman of Skyline Builders Group Holding Limited.

ABOUT THE TICKER CHANGE
The ticker symbol change from KAZR to CRMN will be effective on Nasdaq on November 12, 2026. No action is required by current KAZR shareholders in connection with this change.

ABOUT SKYLINE BUILDERS GROUP HOLDING LIMITED
Skyline Builders Group Holding Limited (NASDAQ: KAZR) is a Cayman Islands exempted company with limited liability with its main assets focused on the construction industry in Asia.

In the third quarter of 2025, a group of US investors, led by American Ventures, took control of the Company via a significant cash injection with a goal to divest of the legacy Asian construction business and acquire assets in the critical material supply chain.

Skyline seeks to become a highly strategic supplier of critical minerals and nuclear fuels and will focus on prioritizing security of supply for US customers. In November 2025, it subscribed for an approximate 20% membership interest in Kaz Resources LLC, a company involved in the critical materials supply chain.

FORWARD LOOKING STATEMENTS
This press release contains forward-looking statements that are subject to various risks and uncertainties. These forward-looking statements include statements which may be accompanied by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential,” or other similar expressions. The Company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct (for example, as to when or whether the new equity financing or the direct listing will be completed, as these are outside Skyline’s control), and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s registration statement and in its other filings with the SEC.

NO OFFER OR SOLICITATION
 This press release is not a proxy statement or solicitation of a proxy, consent or authorization with respect to any securities and shall not constitute an offer to sell or a solicitation of an offer to buy any securities, or a solicitation of any vote or approval, nor shall there be any sale of securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of the Securities Act of 1933, as amended, or an exemption therefrom.

For more information, please contact:

Skyline Builders Group Holding Limited
Investor Relations Department
Email: investors@skylinebuildersgroupholding.com 

8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:	Rathbones Group Plc
(b) Owner or controller of interests and short positions disclosed, if different from 1(a):  The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.
(c) Name of offeror/offeree in relation to whose relevant securities this form relates:  Use a separate form for each offeror/offeree	Gresham House Energy Storage
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
(e) Date position held/dealing undertaken:  For an opening position disclosure, state the latest practicable date prior to the disclosure	11/11/2026
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?  If it is a cash offer or possible cash offer, state “N/A”	No

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:	1p Ordinary Shares
	Interests		Short positions
	Number	%	Number	%
(1) Relevant securities owned and/or controlled:	12,088,779	2.12%
(2) Cash-settled derivatives:
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:
TOTAL:	12,088,779	2.12%

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security	Purchase/sale	Number of securities	Price per unit
1p Ordinary Shares	Sale	5,750	109.5p
1p Ordinary Shares	Sale	30,000	110.3001p
1p Ordinary Shares	Purchase	4,750	109.589p

(b) Cash-settled derivative transactions

Class of relevant security	Product description e.g. CFD	Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position	Number of reference securities	Price per unit

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security	Product description e.g. call option	Writing, purchasing, selling, varying etc.	Number of securities to which option relates	Exercise price per unit	Type e.g. American, European etc.	Expiry date	Option money paid/ received per unit

(ii) Exercise

Class of relevant security	Product description e.g. call option	Exercising/ exercised against	Number of securities	Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security	Nature of dealing e.g. subscription, conversion	Details	Price per unit (if applicable)
1p Ordinary Shares

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none”

None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?

No

Date of disclosure:	12/11/2026
Contact name:	Nicky Vaughan – Compliance Department
Telephone number:	0151 243 7224

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at.

Toronto, Ontario, Nov. 12, 2026 (GLOBE NEWSWIRE) — Fort Technology Inc. (Nasdaq: FRTT) (“Fort” or the “Company”) today announced that it has entered into securities purchase agreements with two institutional investors for the issuance of unsecured convertible promissory notes in an aggregate principal amount of up to $20,000,000.

The Company intends to use the net proceeds from the financing for general working capital and to support its operations, including, among other things, the activities of its majority-owned subsidiary Logia USA related to fuel integrity solutions for data centers and other mission-critical facilities.

The notes, subject to a 10% original issue discount, will be issued in an initial tranche of $2,200,000 principal, followed by additional quarterly tranches, at the Company’s discretion, of up to $2,200,000 principal (with the final tranche of up to $2,400,000 principal), subject to the terms of the agreements. The notes bear interest at 8% per annum, mature 28 months after issuance, and are convertible into common shares of the Company at the lower of a fixed price and 88% of the lowest daily VWAP during the 20 trading days preceding conversion, subject to a floor price. Concurrently with each note, the investors will receive warrants to purchase common shares of the Company, exercisable for five years. In addition, the Company has agreed to issue to the investors common shares with an aggregate value of $1,000,000 as a commitment fee.

The securities to be issued have not been registered under the U.S. Securities Act of 1933, as amended, or any state securities laws, and may not be offered or sold in the United States absent registration or an applicable exemption from such registration requirements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities.

About Fort Technology

Fort is engaged in the retail sale of consumer products, primarily serving the pest control and remedial repair industries. Fort develops, markets and sells a range of products for both amateur and professional customers under its proprietary brands, including Roshield, Entopest, Rempro and BirdGo. Products are sold primarily through Amazon marketplaces in the United Kingdom and Europe as well as through other online sales channels. Fort currently serves customers throughout the United Kingdom and continental Europe and is expanding its operations into the United States, including through its majority-owned subsidiary Logia USA Inc., a company focused on selling advanced fuel integrity solutions for data centers and other mission-critical facilities in the United States.

For further information, please contact:

Gabi Kabazo
Chief Executive Officer
Fort Technology Inc.
Telephone: (604) 833-6820
Email: Office@Fort-Tech.io

Cautionary Note Regarding Forward-Looking Information

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and applicable Canadian securities laws. Fort intends such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements can be about future events, including statements regarding the financing, including the funding of subsequent tranches and the intended use of proceeds, and statements regarding Fort’s intentions, objectives, plans, expectations, assumptions and beliefs about future events, including Fort’s expectations with respect to the financial and operating performance of its business, its capital position, and future growth. The words “anticipate”, “believe”, “expect”, “project”, “predict”, “will”, “forecast”, “estimate”, “likely”, “intend”, “outlook”, “should”, “could”, “may”, “target”, “plan” and other similar expressions can generally be used to identify forward-looking statements. Any forward-looking statements in this press release are based on management’s current expectations of future events and are subject to a number of risks and uncertainties that could cause actual results to differ materially and adversely from those set forth in or implied by such forward-looking statements. For a more detailed description of the risks and uncertainties affecting the Company, reference is made to the Company’s reports filed from time to time with the Securities and Exchange Commission (“SEC”), including, but not limited to, the risks detailed in the Company’s registration statement on Form 20-F (File No. 001-43178), as amended, as filed with the SEC on May 1, 2026 or the Company’s publicly filed documents which are available on SEDAR+ at www.sedarplus.ca. All forward-looking statements contained in this press release speak only as of the date on which they were made. Fort undertakes no obligation to update such statements to reflect changes in assumptions or changes in events that occur or circumstances that exist after the date on which they were made other than as required by applicable laws, rules and regulations.

HOUSTON, Nov. 12, 2026 (GLOBE NEWSWIRE) — Intuitive Machines, Inc. (Nasdaq: LUNR, “Intuitive Machines,” or the “Company”), leading space technology and infrastructure services company, today announced its financial results for the third quarter ended September 30, 2026.

Intuitive Machines CEO Steve Altemus said, “In the third quarter, we delivered record financial performance across the board. These results are an important proof point in our transformation from a company that advanced the state of lunar exploration into a next-generation space prime developing and integrating the technology, infrastructure and services that enable customers to achieve their differentiated missions across space.”

Highlights

• Awarded as a vendor for NASA’s $10 billion (+$5 billion option) IDIQ contract in Q4 for its next-generation Commercial Lunar Payload Services 2 (CLPS 2) contract designed to support more capable cargo missions at greater frequency, advancing Artemis and Moon Base infrastructure requirements, including transportation, mobility, power, habitats, and logistics
• Booked $450 million of new awards and Goonhilly acquired backlog driven primarily by Accelerated Missile Defense Tranche 3 (“AMDT3”) constellation, NASA’s Jet Propulsion Laboratory EAGLE-VSWIR, and Hartford, two IM 300™ series platforms for a National Security Space application
• Contracted with NASA’s Jet Propulsion Laboratory (JPL) for FALCON-RADAR in Q4, which is part of the Fleet for the Atmospheric Linking Commercial Observations with NASA, an Earth observation mission that will study clouds and convection from space
• Accelerated plans for Near Space Network cislunar constellation, Altus-2 through Altus-5 to deploy together in 2028 on a NASA provided launch vehicle
• Closed Goonhilly Earth Station and COMSAT acquisition to expand our space‑to‑ground data services network configured to support missions across LEO, MEO, GEO, cislunar, and deep space environments

Financial Highlights

• Achieved record quarterly revenue of $269 million driven by execution across satellite production, lunar delivery, lunar data services, and ground communication networks
• Converted record revenue to record gross margin of $69 million or 26% driven by increased contribution from our satellite production business, higher volume, and net favorable one-time program adjustments, which also includes EAC and other cost adjustments
• Reported record quarterly cash from operations of positive $66 million with capital expenditures of $33 million, resulting in positive free cash flow of $33 million
• Ended Q3 with record backlog of $1.9 billion, an increase of $1.7 billion from year-end 2025 as Intuitive Machines booked record levels of diverse awards throughout the year across civil, commercial, and national security space customers

Mr. Altemus continued, “As we look to turn the corner into 2027, we remain laser focused on IM-3 along with our first Altus-1 lunar satellite, which remains on track for a planned launch in the March/April timeframe. In addition, our emphasis will be to continue to scale execution and accelerate growth. We expect to convert contracted backlog into revenue through repeatable production, operational excellence, and reliable customer delivery.”

Outlook

• Full-year 2026 revenue of $920 – $950 million
• Full-year 2026 Adjusted EBITDA positive

Conference Call Information

Intuitive Machines will host a conference call today, November 12, 2026, at 8:30 am Eastern Time to discuss these results. A link to the live webcast of the earnings conference call will be made available on the investors portion of the Intuitive Machines’ website at https://investors.intuitivemachines.com.

Following the conference call, a webcast replay will be available through the same link on the investors portion of the Intuitive Machines’ website at https://investors.intuitivemachines.com.

Key Business Metrics and Non-GAAP Financial Measures

In addition to the GAAP financial measures set forth in this press release, the Company has included certain financial measures that have not been prepared in accordance with generally accepted accounting principles (“GAAP”) and constitute “non-GAAP financial measures” as defined by the SEC. This includes adjusted EBITDA (“Adjusted EBITDA”), Free Cash Flow, and Backlog.

Adjusted EBITDA is a key performance measure that our management team uses to assess the Company’s operating performance and is calculated as net income (loss) excluding results from non-operating sources including interest income or interest expense from cash deposits, loans, or investments, transaction and integration costs related to acquisitions, gain on extinguishing of debt, non-recurring legal expenses, share-based compensation, change in fair value instruments, gain or loss on issuance of securities, depreciation, impairment of property and equipment, and provision for income taxes. Intuitive Machines has included Adjusted EBITDA because we believe it is helpful in highlighting trends in the Company’s operating results and because it is frequently used by analysts, investors, and other interested parties to evaluate companies in our industry.

Adjusted EBITDA has limitations as an analytical measure, and investors should not consider it in isolation or as a substitute for analysis of the Company’s results as reported under GAAP. Other companies, including companies in Intuitive Machines’ industry, may calculate Adjusted EBITDA differently, which reduces its usefulness as a comparative measure. Because of these limitations, you should consider Adjusted EBITDA alongside other financial performance measures, including various cash flow metrics, net income (loss) and our other GAAP results. A reconciliation of Adjusted EBITDA to the most directly comparable GAAP financial measure is included below under the heading “Reconciliation of GAAP to Non-GAAP Financial Measure.”

We define free cash flow as net cash (used in) provided by operating activities less purchases of property and equipment. We believe that free cash flow is a meaningful indicator of liquidity that provides information to management and investors about the amount of cash generated from operations that, after purchases of property and equipment, can be used for strategic initiatives, including continuous investment in our business and strengthening our balance sheet. Free Cash Flow has limitations as a liquidity measure, and you should not consider it in isolation or as a substitute for analysis of our cash flows as reported under GAAP. Some of these limitations are: Free Cash Flow is not a measure calculated in accordance with GAAP and should not be considered in isolation from, or as a substitute for financial information prepared in accordance with GAAP; Free Cash Flow may not be comparable to similarly titled metrics of other companies due to differences among methods of calculation; and Free Cash Flow may be affected in the near to medium term by the timing of capital investments, fluctuations in our growth and the effect of such fluctuations on working capital and changes in our cash conversion cycle. A reconciliation of Free Cash Flow to the most directly comparable GAAP financial measure is included below under the heading “Reconciliation of GAAP to Non-GAAP Financial Measure.”

The Company has also included contracted backlog, which is defined as the total estimate of the revenue the Company expects to realize in the future as a result of performing work on awarded contracts, less the amount of revenue the Company has previously recognized. Intuitive Machines monitors its backlog because we believe it is a forward-looking indicator of potential sales which can be helpful to investors in evaluating the performance of its business and identifying trends over time.

About Intuitive Machines

Intuitive Machines is a next-generation space infrastructure company delivering integrated capabilities across spacecraft manufacturing, communications, networks, mission operations, and ground infrastructure to build, connect, and operate systems across Earth orbit, cislunar space, and deep space. Serving commercial, civil, and national security customers, Intuitive Machines is focused on enabling resilient, scalable infrastructure for sustained operations in space.
Forward-Looking Statements

This press release includes “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. These statements that do not relate to matters of historical fact should be considered forward looking. These forward-looking statements generally are identified by the words such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “strive,” “would,” “strategy,” “outlook,” the negative of these words or other similar expressions, but the absence of these words does not mean that a statement is not forward-looking. These forward-looking statements include but are not limited to statements regarding: our expectations and plans related to any proposed business combination; our expectations and plans relating to our missions to the Moon, including the expected timing of launch and our progress in preparation thereof; our expectations with respect to, among other things, demand for our product portfolio, our submission of bids for contracts; our expectations regarding revenue for government contracts awarded to us; our expectations regarding changes to government contracts or programs; our operations, our financial performance and our industry; our business strategy, business plan, and plans to drive long-term sustainable shareholder value; information presented under “Outlook,” or “Guidance” including, our expectations on revenue generation, backlog, Adjusted EBITDA, and cash. These forward-looking statements reflect the Company’s predictions, projections, or expectations based upon currently available information and data. Our actual results, performance or achievements may differ materially from those expressed or implied by the forward-looking statements, and you are cautioned not to place undue reliance on these forward looking statements. The following important factors and uncertainties, among others, could cause actual outcomes or results to differ materially from those indicated by the forward-looking statements in this presentation: our reliance upon the efforts of our Board and key personnel to be successful; our limited operating history; our failure to manage our growth effectively; competition from existing or new companies; unsatisfactory safety performance of our spaceflight systems or security incidents at our facilities; cyber incidents; failure of the market for commercial spaceflight to achieve the growth potential we expect; any delayed launches, launch failures, failure of our satellites or lunar landers to reach their planned orbital locations, significant increases in the costs related to launches of satellites and lunar landers, and insufficient capacity available from satellite and lunar lander launch providers; our customer concentration; risks associated with commercial spaceflight, including any accident on launch or during the journey into space; risks associated with the handling, production and disposition of potentially explosive and ignitable energetic materials and other dangerous chemicals in our operations; our reliance on a limited number of suppliers for certain materials and supplied components; failure of our products to operate in the expected manner or defects in our products; counterparty risks on contracts entered into with our customers and failure of our prime contractors to maintain their relationships with their counterparties and fulfill their contractual obligations; failure to successfully defend protest from other bidders for government contracts; failure to comply with various laws and regulations relating to various aspects of our business and any changes in the funding levels of various governmental entities with which we do business; our failure to protect the confidentiality of our trade secrets and know how; our failure to comply with the terms of third-party open source software our systems utilize; our ability to maintain an effective system of internal control over financial reporting, and to address and remediate material weaknesses in our internal control over financial reporting; the U.S. government’s budget deficit and the national debt, as well as any inability of the U.S. government to complete its budget process for any government fiscal year, and our dependence on U.S. government contracts and funding by the government for the government contracts; our failure to comply with U.S. export and import control laws and regulations and U.S. economic sanctions and trade control laws and regulations; uncertain global macro-economic and political conditions and rising inflation; our history of losses and failure to achieve profitability and our need for substantial additional capital to fund our operations; the fact that our financial results may fluctuate significantly from quarter to quarter; our holding company status; the risk that our business and operations could be significantly affected if it becomes subject to any litigation, including securities litigation or stockholder activism; our public securities’ potential liquidity and trading; and other public filings and press releases other factors detailed under the section titled Part I, Item 1A. Risk Factors of our Annual Report on Form 10-K for the fiscal year ended December 31, 2025 filed with the Securities and Exchange Commission (the “SEC”), the section titled Part I, Item 2, Management’s Discussion and Analysis of Financial Condition and Results of Operations and the section titled Part II. Item 1A. “Risk Factors” in our most recently filed Quarterly Report on Form 10-Q, and in our subsequent filings with the SEC, which are accessible on the SEC’s website at www.sec.gov.

These forward-looking statements are based on information available as of the date of this presentation and current expectations, forecasts, and assumptions, and involve a number of judgments, risks, and uncertainties. Accordingly, forward-looking statements should not be relied upon as representing our views as of any subsequent date, and we do not undertake any obligation to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events, or otherwise, except as may be required under applicable securities laws.

Contacts

For investor inquiries:
investors@intuitivemachines.com

For media inquiries:
press@intuitivemachines.com

INTUITIVE MACHINES, INC.
Condensed Consolidated Balance Sheets
(In thousands)
(Unaudited)
	September 30, 2026				December 31, 2025
ASSETS
Current assets
Cash and cash equivalents	$	463,810			$	582,606
Restricted cash		13,171				2,733
Trade accounts receivable, net		113,528				12,193
Contract assets		120,259				12,236
Inventory		70,622				—
Advances to suppliers		34,041				3,353
Prepaid and other current assets		25,063				5,693
Total current assets		840,494				618,814
Orbital receivables, non-current		208,246				—
Property and equipment, net		326,732				68,550
Intangible assets, net		274,866				12,968
Goodwill		406,653				18,697
Operating lease right-of-use assets		175,069				36,755
Finance lease right-of-use assets		70				94
Other assets		3,271				1,276
Total assets	$	2,235,401			$	757,154
LIABILITIES, MEZZANINE EQUITY AND SHAREHOLDERS’ EQUITY (DEFICIT)
Current liabilities
Accounts payable and accrued expenses	$	139,210			$	22,199
Accounts payable – affiliated companies		5,368				1,723
Contract liabilities, current		293,506				57,368
Operating lease liabilities, current		25,023				10,466
Finance lease liabilities, current		20				48
Other current liabilities		104,080				33,028
Total current liabilities		567,207				124,832
Long-term debt, net		336,860				335,335
Contract liabilities, non-current		1,196				6,341
Pension and other postretirement benefits		43,049				—
Operating lease liabilities, non-current		147,659				26,290
Finance lease liabilities, non-current		14				20
Warrant liabilities		51,428				60,394
Other non-current liabilities		61,347				240
Total liabilities		1,208,760				553,452
Commitments and contingencies
MEZZANINE EQUITY
Series A preferred stock subject to possible redemption		7,120				6,613
Redeemable noncontrolling interests		783,728				951,536
SHAREHOLDERS’ DEFICIT
Class A common stock		18				12
Class C common stock		6				6
Treasury Stock		(33,525	)			(33,525	)
Paid-in capital		—				—
Accumulated earnings (deficit)		268,336				(721,457	)
Accumulated other comprehensive loss		(15	)			—
Total shareholders’ equity (deficit) attributable to the Company		234,820				(754,964	)
Noncontrolling interests		973				517
Total shareholders’ equity (deficit)		235,793				(754,447	)
Total liabilities, mezzanine equity and shareholders’ equity (deficit)	$	2,235,401			$	757,154

INTUITIVE MACHINES, INC.
Condensed Consolidated Statements of Operations
(In thousands)
(Unaudited)
	Three Months Ended September 30,								Nine Months Ended September 30,
	2026				2025				2026				2025
Revenues:
Product revenue	$	215,118			$	—			$	523,407			$	—
Service revenue		54,138				50,987				132,891				163,824
Grant revenue		92				1,450				5,948				1,450
Total revenues		269,348				52,437				662,246				165,274
Operating expenses:
Cost of product revenue (excluding depreciation and amortization)		152,588				—				385,829				—
Cost of service revenue (excluding depreciation and amortization)		39,595				39,574				114,381				144,546
Cost of grant revenue (excluding depreciation and amortization)		101				1,459				5,962				1,459
Cost of service revenue (excluding depreciation and amortization) – affiliated companies		7,762				5,736				20,799				18,767
Total cost of revenues		200,046				46,769				526,971				164,772
Depreciation and amortization		13,180				815				41,155				2,190
Research and development		7,458				3,957				20,776				5,329
General and administrative expense (excluding depreciation and amortization)		82,913				16,315				193,930				47,119
Total operating expenses		303,597				67,856				782,832				219,410
Operating loss		(34,249	)			(15,419	)			(120,586	)			(54,136	)
Other income (expense), net:
Interest income		2,963				4,833				5,870				9,752
Interest expense		(4,532	)			(1,344	)			(13,900	)			(1,442	)
Change in fair value of earn-out liabilities		—				—				—				(33,369	)
Change in fair value of warrant liabilities		30,010				1,950				8,966				31,919
Change in fair value of contingent consideration liabilities		3,618				—				2,207				—
Other income, net		(1,164	)			25				(1,270	)			90
Total other income, net		30,895				5,464				1,873				6,950
Loss before income taxes		(3,354	)			(9,955	)			(118,713	)			(47,186	)
Income tax expense		—				(5	)			(10	)			(5	)
Net loss		(3,354	)			(9,960	)			(118,723	)			(47,191	)
Net income (loss) attributable to redeemable noncontrolling interest		256				(3,445	)			(32,009	)			(4,944	)
Net income attributable to noncontrolling interest		406				327				1,134				1,172
Net loss attributable to the Company		(4,016	)			(6,842	)			(87,848	)			(43,419	)
Less: Preferred dividends		(173	)			(158	)			(502	)			(456	)
Net loss attributable to Class A common shareholders	$	(4,189	)		$	(7,000	)		$	(88,350	)		$	(43,875	)
Net loss per share
Net loss per share of Class A common stock – basic and diluted	$	(0.02	)		$	(0.06	)		$	(0.55	)		$	(0.38	)
Weighted-average common shares outstanding
Weighted average shares outstanding – basic and diluted		173,425,260				117,815,856				161,252,158				114,150,168

INTUITIVE MACHINES, INC.
Condensed Consolidated Statements of Cash Flows
(In thousands)
(Unaudited)
	Three Months Ended September 30,								Nine Months Ended September 30,
	2026				2025				2026				2025
Cash flows from operating activities:
Net loss	$	(3,354	)		$	(9,960	)		$	(118,723	)		$	(47,191	)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization		13,180				815				41,155				2,190
Provision for credit losses		9,540				—				9,897				135
Amortization of debt discount and issuance costs		739				243				1,525				243
Share-based compensation expense		10,610				1,416				29,943				6,780
Change in fair value of earn-out liabilities		—				—				—				33,369
Change in fair value of warrant liabilities		(30,010	)			(1,950	)			(8,966	)			(31,919	)
Change in fair value of contingent consideration liabilities		(3,618	)			—				(2,207	)			—
Other		836				—				(2,975	)			177
Changes in operating assets and liabilities:
Trade and other receivables, net		2,557				13,246				(10,822	)			21,299
Inventory		(10,657	)			—				(14,451	)			—
Contract assets		(68,968	)			(1,737	)			(84,581	)			24,417
Prepaid expenses		(3,857	)			(4,362	)			(24,535	)			(5,493	)
Orbital receivables, net		(1,609	)			—				14,537				—
Other assets, net		(72,930	)			900				(76,583	)			1,991
Accounts payable and accrued expenses		54,177				(4,245	)			54,574				(3,940	)
Accounts payable – affiliated companies		2,498				(2,082	)			3,645				(524	)
Contract liabilities – current and long-term		74,060				(3,848	)			68,218				(11,724	)
Pension and other postretirement benefits		(5,703	)			—				(11,757	)			—
Other liabilities		98,681				4,385				86,400				3,167
Net cash provided by (used in) operating activities		66,172				(7,179	)			(45,706	)			(7,023	)
Cash flows from investing activities:
Purchase of property and equipment		(32,700	)			(11,811	)			(66,641	)			(25,987	)
Acquisition of businesses, net of cash acquired		(17,825	)			—				(464,887	)			—
Net cash used in investing activities		(50,525	)			(11,811	)			(531,528	)			(25,987	)
Cash flows from financing activities:
Proceeds from issuance of securities		98,103				—				511,875				—
Warrants exercised		—				—				—				176,620
Redemption of warrants		—				—				—				(66	)
Transaction costs related to the issuance of securities		(1,627	)			—				(13,336	)			—
Repurchase of Class A Common Stock		—				—				—				(20,700	)
Proceeds from issuance of convertible notes, net of discount		—				335,513				—				335,513
Payment of debt issuance costs		—				(929	)			—				(929	)
Purchase of capped call transactions		—				(36,777	)			—				(36,777	)
Repayment of loans		(8,872	)			—				(8,872	)			—
Settlement of securitization facility		(5,064	)			—				(18,652	)			—
Payment of withholding taxes from share-based awards		(228	)			(217	)			(1,461	)			(4,757	)
Distributions to noncontrolling interests		—				(1,526	)			(678	)			(1,526	)
Net cash provided by financing activities		82,312				296,064				468,876				447,378
Net increase (decrease) in cash, cash equivalents and restricted cash		97,959				277,074				(108,358	)			414,368
Cash, cash equivalents and restricted cash at beginning of the period		379,022				346,943				585,339				209,649
Cash, cash equivalents and restricted cash at end of the period		476,981				624,017				476,981				624,017
Less: restricted cash		13,171				2,042				13,171				2,042
Cash and cash equivalents at end of the period	$	463,810			$	621,975			$	463,810			$	621,975

INTUITIVE MACHINES, INC.
Reconciliation of GAAP to Non-GAAP Financial Measure
Adjusted EBITDA
The following table presents a reconciliation of net loss, the most directly comparable financial measure presented in accordance with GAAP, to Adjusted EBITDA.
	Three Months Ended September 30,								Nine Months Ended September 30,
(in thousands)	2026				2025				2026				2025
Net loss	$	(3,354	)		$	(9,960	)		$	(118,723	)		$	(47,191	)
Adjusted to exclude the following:
Income tax expense		—				5				10				5
Depreciation and amortization		13,180				815				41,155				2,190
Interest income		(2,963	)			(4,833	)			(5,870	)			(9,752	)
Interest expense		4,532				1,344				13,900				1,442
Transaction and integration costs related to acquisitions		9,574				—				37,471				—
Non-recurring legal expense		10,304				—				10,304				—
Share-based compensation expense		10,610				1,416				29,943				6,780
Change in fair value of earn-out liabilities		—				—				—				33,369
Change in fair value of warrant liabilities		(30,010	)			(1,950	)			(8,966	)			(31,919	)
Change in fair value of contingent consideration liabilities		(3,618	)			—				(2,207	)			—
Adjusted EBITDA	$	8,255			$	(13,164	)		$	(2,983	)		$	(45,076	)

Free Cash Flow

We define free cash flow as net cash (used in) provided by operating activities less purchases of property and equipment. We believe that free cash flow is a meaningful indicator of liquidity that provides information to management and investors about the amount of cash generated from operations that, after purchases of property and equipment, can be used for strategic initiatives, including continuous investment in our business and strengthening our balance sheet.

Free Cash Flow has limitations as a liquidity measure, and you should not consider it in isolation or as a substitute for analysis of our cash flows as reported under GAAP. Some of these limitations are:

• Free Cash Flow is not a measure calculated in accordance with GAAP and should not be considered in isolation from, or as a substitute for financial information prepared in accordance with GAAP.
• Free Cash Flow may not be comparable to similarly titled metrics of other companies due to differences among methods of calculation.
• Free Cash Flow may be affected in the near to medium term by the timing of capital investments, fluctuations in our growth and the effect of such fluctuations on working capital and changes in our cash conversion cycle.

The following table presents a reconciliation of net cash used in operating activities, the most directly comparable financial measure presented in accordance with GAAP, to free cash flow:

	Nine Months Ended September 30,
(in thousands)	2026				2025
Net cash used in operating activities	$	(45,706	)		$	(7,023	)
Purchases of property and equipment		(66,641	)			(25,987	)
Free cash flow	$	(112,347	)		$	(33,010	)

Backlog

The following table presents our backlog as of the periods indicated:

(in thousands)		September 30, 2026			December 31, 2025
Backlog		$	1,866,758		$	213,070

Backlog increased by approximately $1.65 billion as of September 30, 2026, compared to December 31, 2025. This increase includes $612.8 million of acquired backlog from the January 2026 Lanteris acquisition and $31.7 million from the August 2026 Goonhilly acquisition, as well as $1.77 billion in new awards. The new awards were primarily driven by a multi-satellite program supporting three commercial satellites, Space Development Agency Proliferated Warfighter Space Architecture tranche 3 tracking layer, Accelerated Missile Defense Tranche 3 (“AMDT3”) constellation, NASA’s Jet Propulsion Laboratory Explorer for Artemis Geology, Lunar, and Earth – Visible to Shortwave Infrared (“EAGLE-VSWIR”), and Hartford, two IM 300™ series platforms for a National Security Space application. Additionally, we recognized new awards or expanded contract values for the IM-5 and IM-6 missions, the NSN contract, and various other contract awards. These increases were partially offset by performance on existing contracts that resulted in recognized revenue of $662.2 million, and several adjustments of $94.7 million primarily related to the descoping of the remaining Power Propulsion Element (“PPE”) contract as well as partial descoping of a rideshare contract associated with the IM-4 mission.

This press release was published by a CLEAR® Verified individual.

Delivered record Q3 Contribution ex-TAC and programmatic revenue, highlighted by continued enterprise momentum and 39% year-over-year CTV revenue growth, alongside a 22% year-over-year increase in Adjusted EBITDA 

Reaffirmed full-year 2026 Contribution ex-TAC, programmatic revenue and Adjusted EBITDA guidance following three top line guidance increases earlier this year

Extended $40 million share repurchase program authorization and currently expects to resume share repurchases in the second half of Q4 2026

NEW YORK, Nov. 12, 2026 (GLOBE NEWSWIRE) — Nexxen International Ltd. (NASDAQ: NEXN) (“Nexxen” or the “Company”), the advertising technology platform powered by unique data and media, announced today its financial results for the three and nine months ended September 30, 2026.

Q3 2026 Financial Highlights

• Record Q3 Contribution ex-TAC of $100.3 million, up 8% year-over-year.
• Record Q3 programmatic revenue of $97.8 million, up 9% year-over-year.
• Record Q3 CTV revenue of $34.1 million, up 39% year-over-year.
• Programmatic revenue increased to 95% of total revenue, compared to 94% in Q3 2025.
• CTV revenue increased to 35% of programmatic revenue, compared to 27% in Q3 2025.
• Video revenue represented 66% of programmatic revenue, compared to 70% in Q3 2025.
• Adjusted EBITDA of $34.5 million, up 22% year-over-year, representing a 34% Adjusted EBITDA margin on both a Contribution ex-TAC and total revenue basis, compared to $28.2 million and a 30% Adjusted EBITDA margin on a Contribution ex-TAC and total revenue basis in Q3 2025.
• $152.9 million in cash and cash equivalents, no long-term debt and $50 million available under the Company’s undrawn revolving credit facility as of September 30, 2026.

“We delivered record Q3 Contribution ex-TAC and programmatic revenue, highlighted by strength across enterprise, CTV, mobile in-app and data products, while returning to Adjusted EBITDA growth and margin expansion following three top line guidance increases earlier this year,” said Ofer Druker, Chief Executive Officer of Nexxen. “Our investments across data, AI, CTV, mobile in-app and platform capabilities are driving tangible results, supporting what we believe are continued share gains across agencies, brands and major holding companies.”

Mr. Druker added, “We are also advancing our strategy to capitalize on the AI-driven transformation of the advertising ecosystem. As Nexxen has evolved, we think of ourselves not simply as a DSP, data platform and SSP, but increasingly as an AI-native, full-funnel performance advertising platform, powering better outcomes for both buyers and sellers while enabling them to transact directly in a streamlined, transparent and unified agentic environment. As AI agents play a greater role, we believe Nexxen’s in-platform and interoperable agentic capabilities, powered by nexAI, unique data and end-to-end infrastructure, position us to help lead that evolution. Based on preliminary results, we believe October was our best top line month ever, and with momentum accelerating across our key growth engines, we believe Nexxen is well-positioned to deliver an all-time record quarter in Q4 and enter 2027 from a position of strength.”

Financial Guidance and Outlook

• Nexxen reaffirms its prior full-year 2026 financial guidance following three top line guidance increases earlier this year:
   
  • Contribution ex-TAC in the range of $388 – $402 million, representing approximately 12% year-over-year growth at the midpoint
  • Programmatic revenue in the range of $380 – $393 million, representing approximately 13% year-over-year growth at the midpoint
  • Adjusted EBITDA in the range of $122 – $132 million, representing approximately 10% year-over-year growth and an Adjusted EBITDA margin of 32% on a Contribution ex-TAC basis at the midpoint
• The Company’s reaffirmed guidance reflects continued year-over-year momentum across enterprise customers, increased end-to-end platform utilization and strength within CTV, mobile in-app and data products thus far in Q4 2026. Based on current visibility, including preliminary unaudited results for October, which the Company believes represented its best top line month ever, management anticipates all-time record Contribution ex-TAC and programmatic revenue in Q4 2026.
• While Nexxen benefitted from political advertising related to the U.S. mid-term election cycle in Q3 and early Q4 2026, management does not expect political revenue comparisons to represent a meaningful growth headwind in 2027.
• Management currently anticipates all-time record CTV revenue in Q4 2026, driven by broad-based momentum across Nexxen’s end-to-end CTV solutions and the continued ramp of Nexxen TV Home Screen, which is progressing in line with management’s expectations. Based on early results and a strong pipeline, management continues to believe the offering will represent an increasingly meaningful growth catalyst into 2027 and beyond.
• Management currently expects sequential and year-over-year Adjusted EBITDA growth and margin expansion in Q4 2026, with most incremental Contribution ex-TAC expected to flow to the Company’s Adjusted EBITDA, demonstrating the operating leverage enabled by Nexxen’s end-to-end model. The Company intends to continue investing in AI, data and infrastructure, alongside performance-based CTV and mobile in-app capabilities, to support long-term programmatic revenue growth and operating leverage.

Q3 2026 Operational Highlights and Recent Developments

• Significantly enhanced Nexxen’s unique data capabilities, enabling additional differentiated signals to enter its platform faster, improving ease of use and performance, advancing nexAI and supporting the Company’s long-term growth opportunities. Nexxen launched new first-party data onboarding capabilities that allow customers to prepare audiences for activation in 24 hours or less, supported by an enhanced Unified Identity Graph that incorporates additional online and offline signals and nearly doubles Nexxen’s global identity footprint.
   
• Advanced Nexxen’s in-platform and interoperable agentic AI capabilities, expanding how customers can interact with and derive value from its platform while creating new growth opportunities. Nexxen now has several live in-platform agents spanning key customer workflows including reporting, QA, audience intelligence, incremental spend analysis and campaign and deal troubleshooting, with additional agents expected to be released in the coming quarters. These capabilities are also accessible through Nexxen’s MCP integrations, alongside a broader suite of AI-driven tools supporting campaign management workflows. Eight agency and holding company partners are now actively testing or utilizing Nexxen within their own AI-driven environments, with initial feedback indicating the Company’s agentic capabilities are advanced relative to other platforms.
   
• Drove continued enterprise momentum in Q3, generating over 40% year-over-year Contribution ex-TAC growth from enterprise customers that access the Nexxen DSP on a self-service or platform-managed basis and activating many additional advertisers through them, with several citing Nexxen’s data capabilities and agentic AI solutions as key catalysts. Enterprise customers have continued to consolidate spend and expand their use of Nexxen’s combined data, media and technology solutions, driving greater end-to-end platform utilization. Third-party studies, including from DISQO, an independent advertising effectiveness measurement provider, have highlighted double- to triple-digit percentage improvements across metrics such as awareness, conversion, campaign performance and cost efficiencies on campaigns run through Nexxen compared to peer platforms, which the Company believes supports the benefits of its end-to-end strategy.
   
• Advanced Nexxen TV Home Screen through the standardization of Smart TV home screen inventory specifications across OEMs, expanding Nexxen’s long-term CTV revenue opportunity. Nexxen TV Home Screen, now also available across EMEA, provides access to premium inventory from V (formerly VIDAA), TCL, TiVo Ads and others, with additional major OEMs in testing or active discussions. Programmatic access is supported through Nexxen DSP and other industry-leading platforms, including The Trade Desk, Google’s Display & Video 360 and StackAdapt, with spend scaling in line with expectations thus far in Q4 and a strong pipeline supporting continued growth.
   
• Expanded CTV media footprint through recent integrations with premium partners including Disney, Sling TV and others, further strengthening Nexxen’s CTV coverage, which the Company believes ranks among the industry’s highest.
   
• Increased programmatic access to premium CTV formats, making pause ad inventory from partners including DIRECTV Advertising available through Nexxen SSP to buyers using Nexxen DSP and other leading third-party DSPs.
   
• Deepened Nexxen’s partnership with Omnicom’s Acxiom, integrating its consumer intelligence and audience data into Nexxen Discovery to combine interest, purchase and household-level insights with Nexxen’s contextual, behavioral and viewership signals, enabling advertisers to more precisely identify, refine and activate audiences across channels.
   
• Integrated with Shopify, enabling advertisers to connect first-party online and offline e-commerce purchase and conversion signals directly to Nexxen’s unified platform to support measurement and attribution across Nexxen DSP.
   
• Completed the wind-down of RhythmInfluence, Nexxen’s non-programmatic influencer marketing business. The wind-down did not have a material impact on Contribution ex-TAC or Adjusted EBITDA during Q3 2026, nor is it expected to materially impact these measures in Q4 2026. Management continues to evaluate strategic options for its remaining non-programmatic business lines.

Share Repurchase Program and Capital Allocation Updates

• Nexxen’s strong balance sheet and robust cash generation, alongside its absence of long-term debt, provide financial flexibility to simultaneously invest in organic growth, pursue disciplined acquisition opportunities and return capital to shareholders:

• • Nexxen completed its additional $15 million investment in V (formerly VIDAA) during Q3 2026, bringing its total investment to $60 million, representing approximately 6% equity ownership.
  • The Company did not repurchase shares during Q3 2026, as management prioritized maintaining financial flexibility while actively evaluating disciplined bolt-on acquisition opportunities and continuing to invest across Nexxen’s strategic priorities, including AI, data, platform capabilities and go-to-market execution.
  • The Company extended its share repurchase program authorization of up to $40 million and currently expects to resume share repurchases in the second half of Q4 2026. Since March 1, 2022, Nexxen has repurchased 30,928,265 shares, or approximately 39.9% of shares outstanding, investing approximately $265.3 million.
  • Management continues to actively evaluate bolt-on acquisitions that can enhance the Company’s platform capabilities, competitive positioning and long-term growth, with a focus on opportunities that management expects would be accretive to Contribution ex-TAC and Adjusted EBITDA.

Financial Highlights for the Three and Nine Months Ended September 30, 2026 ($ in millions, except per share amounts)

		Three months ended September 30							Nine months ended September 30
		2026			2025		%		2026		2025		%
IFRS Highlights
Revenue		102.9			94.8		9%		290.3		264.1		10%
Programmatic revenue		97.8			89.6		9%		275.0		246.3		12%
Operating profit		12.7			7.3		75%		12.0		19.4		(38%)
Net income margin on a gross profit basis		15%			6%				4%		8%
Total comprehensive income		10.3			3.8		169%		9.0		17.5		(48%)
Diluted earnings per share		0.18			0.07		150%		0.15		0.23		(36%)
Non-IFRS Highlights
Contribution ex-TAC		100.3			92.6		8%		282.7		255.4		11%
Adjusted EBITDA		34.5			28.2		22%		78.4		81.3		(4%)
Adjusted EBITDA Margin on a Contribution		34%			30%				28%		32%
ex-TAC basis
Non-IFRS net income		19.1			12.0		59%		35.9		40.9		(12%)
Non-IFRS diluted earnings per share		0.32			0.20		60%		0.61		0.66		(6%)

Third Quarter 2026 Financial Results Webcast and Conference Call Details

• When: November 12, 2026, at 9:00 AM ET
• Webcast: A live and archived webcast can be accessed from the Events and Presentations section of Nexxen’s Investor Relations website at https://investors.nexxen.com/
• Participant Dial-In Numbers:
  • U.S. / Canada Toll-Free Dial-In Number: (888) 596-4144
  • U.K. Toll-Free Dial-In Number: +44 800 260 6470
  • International Dial-In Number: +1 (646) 968-2525
  • Conference ID: 4150652

About Nexxen

Nexxen is the advertising technology platform that delivers full-funnel performance powered by unique data and media. Comprised of a demand-side platform (“DSP”) and supply-side platform (“SSP”), with the Nexxen Data Platform at its core, we meet the demands of today’s converging media landscape with exclusive audience intelligence, automation and expertise.

Headquartered in Israel, Nexxen maintains offices throughout North America, Europe and Asia-Pacific and is traded on Nasdaq (NEXN). For more information, please visit nexxen.com.

For further information please contact:

Billy Eckert, Vice President of Investor Relations
ir@nexxen.com

Genevieve Wheeler, Senior Director of Communications
gwheeler@nexxen.com

Forward Looking Statements

This press release contains forward-looking statements, including forward-looking statements within the meaning of Section 27A of the United States Securities Act of 1933, as amended, and Section 21E of the United States Securities Exchange Act of 1934, as amended. Forward-looking statements are identified by words such as “anticipates,” “believes,” “expects,” “intends,” “may,” “can,” “will,” “estimates,” and other similar expressions. However, these words are not the only way Nexxen identifies forward-looking statements. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including without limitation statements regarding anticipated financial results for October, Q4 and full year 2026 and beyond; anticipated benefits of Nexxen’s strategic transactions and commercial partnerships; anticipated features and benefits of Nexxen’s products and service offerings, including anticipated benefits relating to nexAI, MCP and A2A interoperability and the Company’s AI investment strategy; anticipated industry adoption of Nexxen TV Home Screen; Nexxen’s positioning for accelerated growth and continued future growth; Nexxen’s medium- to long-term prospects; management’s belief that Nexxen is well-positioned to benefit from future industry growth trends and Company-specific catalysts; the Company’s plans with respect to its cash reserves as well as its future share repurchase programs, including the expected resumption of share repurchases; the Company’s plans to pursue strategic opportunities for its non-programmatic business lines and other targeted, smaller-scale strategic opportunities to accelerate programmatic revenue growth and expand capabilities, including its acquisition priorities and the expected accretive impact of any acquisition; the expected impact of the wind-down of RhythmInfluence; anticipated benefits from the Company’s strategic partnership with V (formerly VIDAA), as well as any other statements related to Nexxen’s future financial results and operating performance. These statements are neither promises nor guarantees but involve known and unknown risks, uncertainties and other important factors that may cause Nexxen’s actual results, performance or achievements to be materially different from its expectations expressed or implied by the forward-looking statements, including, but not limited to, the following: negative global economic conditions, including risks related to tariff impacts or policy shifts (including trade negotiations or enforcement actions) that could materially affect market sentiment, consumer behavior and advertising demand; global conflicts and war, including the conflict involving Israel and Iran and related regional and international tensions, including U.S. military involvement, and the war and hostilities between Israel and Hamas, Hezbollah and the Houthis in Yemen, and how those conditions may adversely impact Nexxen’s business, customers and the markets in which Nexxen competes; changes in industry trends, and other negative developments in Nexxen’s business or unfavorable legislative or regulatory developments. Nexxen cautions you not to place undue reliance on these forward-looking statements. For a more detailed discussion of these factors, and other factors that could cause actual results to vary materially, interested parties should review the risk factors listed in the Company’s most recent Annual Report filed with the U.S. Securities and Exchange Commission (www.sec.gov) on Form 20-F. Any forward-looking statements made by Nexxen in this press release speak only as of the date of this press release, and Nexxen does not intend to update these forward-looking statements after the date of this press release, except as required by law.

Nexxen and the Nexxen logo are trademarks of Nexxen International Ltd. in the United States and other countries. All other trademarks are the property of their respective owners. The use of the word “partner” or “partnership” in this press release does not mean a legal partner or legal partnership.

Use of Non-IFRS Financial Information

In addition to our IFRS results, we review certain non-IFRS financial measures to help us evaluate our business, measure our performance, identify trends affecting our business, establish budgets, measure the effectiveness of investments in technology and development and sales and marketing and assess our operational efficiencies. These non-IFRS measures include Contribution ex-TAC, Adjusted EBITDA, Adjusted EBITDA Margin, Non-IFRS Net Income and Non-IFRS Earnings per Share, each of which is discussed below.

These non-IFRS financial measures are not intended to be considered in isolation from, as substitutes for, or as superior to the corresponding financial measures prepared in accordance with IFRS. You are encouraged to evaluate these adjustments and review the reconciliation of these non-IFRS financial measures to their most comparable IFRS measures and the reasons we consider them appropriate. It is important to note that the particular items we exclude from, or include in, our non-IFRS financial measures may differ from the items excluded from, or included in, similar non-IFRS financial measures used by other companies. See “Reconciliation of Revenue to Contribution ex-TAC,” “Reconciliation of Total Comprehensive Income to Adjusted EBITDA,” and “Reconciliation of Net Income to Non-IFRS Net Income,” included as part of this press release.

• Contribution ex-TAC: Contribution ex-TAC for Nexxen is defined as gross profit plus depreciation and amortization attributable to cost of revenue and cost of revenue (exclusive of depreciation and amortization) minus Performance (non-programmatic) media costs (“traffic acquisition costs” or “TAC”). Performance (non-programmatic) media costs represent the costs of purchases of impressions from publishers on a cost-per-thousand impression basis in our non-core, non-programmatic Performance activities. Contribution ex-TAC is a supplemental measure of our financial performance that is not required by or presented in accordance with IFRS. Contribution ex-TAC should not be considered as an alternative to gross profit as a measure of financial performance. Contribution ex-TAC is a non-IFRS financial measure and should not be viewed in isolation. We believe Contribution ex-TAC is a useful measure in assessing the performance of Nexxen because it facilitates a consistent comparison against our core business without considering the impact of traffic acquisition costs related to revenue reported on a gross basis.
   
• Adjusted EBITDA: We define Adjusted EBITDA for Nexxen as total comprehensive income for the period adjusted for foreign currency translation differences for foreign operation, tax expenses, financial income, net, depreciation and amortization, stock-based compensation expenses, restructuring and delisting related one-time costs. Adjusted EBITDA is included in the press release because it is a key metric used by management and our Board of Directors to assess our financial performance. Adjusted EBITDA is frequently used by analysts, investors and other interested parties to evaluate companies in our industry. Management believes that Adjusted EBITDA is an appropriate measure of operating performance because it eliminates the impact of expenses that do not relate directly to the performance of the underlying business.
   
• Adjusted EBITDA Margin: We define Adjusted EBITDA Margin as Adjusted EBITDA as a percentage of Contribution ex-TAC.
   
• Non-IFRS Net Income and Non-IFRS Earnings per Share: We define non-IFRS earnings per share as non-IFRS net income divided by non-IFRS weighted-average shares outstanding. Non-IFRS net income is equal to net income excluding amortization of acquired intangibles, restructuring, delisting related one-time costs and stock-based compensation expenses, and also considers the tax effects of non-IFRS adjustments. In periods in which we have non-IFRS net income, non-IFRS weighted-average shares outstanding used to calculate non-IFRS earnings per share include the impact of potentially dilutive shares. Potentially dilutive shares consist of stock options, restricted stock awards, restricted stock units and performance stock units, each computed using the treasury stock method. We believe non-IFRS earnings per share is useful to investors for evaluating our ongoing operational performance and trends on a per share basis and also facilitates comparison of our financial results on a per share basis with other companies, many of which present a similar non-IFRS measure. However, a potential limitation of our use of non-IFRS earnings per share is that other companies may define non-IFRS earnings per share differently, which may make comparison difficult. This measure may also exclude expenses that may have a material impact on our reported financial results. Non-IFRS earnings per share is a performance measure and should not be used as a measure of liquidity. Because of these limitations, we also consider the comparable IFRS measure of net income.

We do not provide a reconciliation of forward-looking non-IFRS financial metrics because reconciling information is not available without an unreasonable effort, such as attempting to make assumptions that cannot reasonably be made on a forward-looking basis to determine the corresponding IFRS metric.

Reconciliation of Total Comprehensive Income to Adjusted EBITDA

		Three months ended September 30						Nine months ended September 30
		2026		2025		%		2026		2025		%
($ in thousands)
Total comprehensive income		10,260		3,809		169%		9,015		17,456		(48%)
Foreign currency translation differences for foreign operation		171		399				(259)		(2,949)
Tax expenses		2,713		4,455				4,031		8,768
Financial income, net		(431)		(1,390)				(779)		(3,849)
Depreciation and amortization		17,375		16,080				51,442		46,868
Stock-based compensation expenses		4,431		4,844				13,632		13,453
Restructuring		–		–				1,323		–
Delisting related one-time costs		–		–				–		1,520
Adjusted EBITDA		34,519		28,197		22%		78,405		81,267		(4%)

Reconciliation of Revenue to Contribution ex-TAC 

		Three months ended September 30						Nine months ended September 30
		2026		2025		%		2026		2025		%
($ in thousands)
Revenue		102,934		94,791		9%		290,294		264,069		10%
Cost of revenue (exclusive of depreciation and amortization)		(17,576)		(16,262)				(52,802)		(39,518)
Depreciation and amortization attributable to cost of revenue		(14,328)		(12,944)				(42,260)		(37,769)
Gross profit (IFRS)		71,030		65,585		8%		195,232		186,782		5%
Depreciation and amortization attributable to cost of revenue		14,328		12,944				42,260		37,769
Cost of revenue (exclusive of depreciation and amortization)		17,576		16,262				52,802		39,518
Performance media cost		(2,585)		(2,229)				(7,582)		(8,712)
Contribution ex-TAC (Non-IFRS)		100,349		92,562		8%		282,712		255,357		11%

Reconciliation of Net Income to Non-IFRS Net Income

		Three months ended September 30										Nine months ended September 30
		2026		2025		%						2026			2025			%
($ in thousands)
Net income		10,431		4,208		148%						8,756			14,507			(40%)
Amortization of acquired intangibles		5,903		5,920								17,670			17,702
Restructuring		–		–								1,323			–
Delisting related one-time costs		–		–								–			1,520
Stock-based compensation expenses		4,431		4,844								13,632			13,453
Tax effect of Non-IFRS adjustments(1)		(1,686)		(2,954)								(5,502)			(6,321)
Non-IFRS net income		19,079		12,018		59%						35,879			40,861			(12%)
Weighted average shares outstanding—		59.0		59.5								58.4			62.3
diluted (in millions)(2)
Non-IFRS diluted earnings per share (in USD)		0.32		0.20		60%						0.61			0.66			(6%)

	(1)		Non-IFRS net income includes the estimated tax impact from the expense items reconciling between net income and non-IFRS net income
	(2)		Non-IFRS earnings per share is computed using the same weighted-average number of shares that are used to compute IFRS earnings per share

CONDENSED CONSOLIDATED INTERIM STATEMENTS OF FINANCIAL POSITION  (Unaudited)
		September 30			December 31
		2026			2025
		USD thousands
Assets
ASSETS:
Cash and cash equivalents		152,911			133,308
Trade receivables, net		227,517			196,101
Other receivables		5,040			6,116
Current tax assets		1,701			1,809
TOTAL CURRENT ASSETS		387,169			337,334
Fixed assets, net		25,471			18,033
Right-of-use assets		34,452			27,005
Intangible assets, net		303,472			318,376
Deferred tax assets		8,225			9,407
Investment in shares		60,000			45,000
Other long-term assets		1,119			918
TOTAL NON-CURRENT ASSETS		432,739			418,739
TOTAL ASSETS		819,908			756,073
Liabilities and shareholders’ equity
LIABILITIES:
Current maturities of lease liabilities		15,681			13,287
Trade payables		246,891			207,020
Other payables		40,237			41,282
Current tax liabilities		377			441
TOTAL CURRENT LIABILITIES		303,186			262,030
Employee benefits		226			213
Long-term lease liabilities		23,571			18,644
Deferred tax liabilities		2,123			515
TOTAL NON-CURRENT LIABILITIES		25,920			19,372
TOTAL LIABILITIES		329,106			281,402
SHAREHOLDERS’ EQUITY:
Share capital		329			324
Share premium		285,621			278,510
Other comprehensive income		607			348
Retained earnings		204,245			195,489
TOTAL SHAREHOLDERS’ EQUITY		490,802			474,671
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY		819,908			756,073

CONDENSED CONSOLIDATED INTERIM STATEMENTS OF OPERATION AND OTHER COMPREHENSIVE INCOME (LOSS) (Unaudited)
	For the nine months ended September 30				For the three months ended September 30
	2026		2025		2026		2025
	USD thousands				USD thousands
Revenues	290,294		264,069		102,934		94,791
Cost of revenues (Exclusive of depreciation and amortization shown separately below)	52,802		39,518		17,576		16,262
Research and development expenses	43,886		42,494		14,124		14,765
Selling and marketing expenses	100,622		90,530		31,615		30,369
General and administrative expenses	29,534		25,233		9,531		10,042
Depreciation and amortization	51,442		46,868		17,375		16,080
Total operating costs	225,484		205,125		72,645		71,256
Operating profit	12,008		19,426		12,713		7,273
Financing income	(2,746)		(5,685)		(1,015)		(1,944)
Financing expenses	1,967		1,836		584		554
Financing income, net	779		3,849		431		1,390
Profit before taxes on income	12,787		23,275		13,144		8,663
Tax expenses	4,031		8,768		2,713		4,455
Profit for the period	8,756		14,507		10,431		4,208
Other comprehensive income (loss) items:
Foreign currency translation differences for foreign operation	259		2,949		(171)		(399)
Total other comprehensive income (loss) for the period	259		2,949		(171)		(399)
Total comprehensive income for the period	9,015		17,456		10,260		3,809
Earnings per share
Basic earnings per share (in USD)	0.15		0.24		0.18		0.07
Diluted earnings per share (in USD)	0.15		0.23		0.18		0.07

CONDENSED CONSOLIDATED INTERIM STATEMENTS OF CHANGES IN EQUITY (Unaudited)
		Share capital		Share premium		Other comprehensive income (loss)		Retained earnings		Total
		USD thousands
Balance as of January 1, 2026		324		278,510		348		195,489		474,671
Total comprehensive income for the period
Profit for the period		–		–		–		8,756		8,756
Other comprehensive income:
Foreign currency translation		–		–		259		–		259
Total comprehensive income for the period		–		–		259		8,756		9,015
Transactions with owners, recognized directly in equity
Own shares acquired		(7)		(7,146)		–		–		(7,153)
Share based compensation		–		14,042		–		–		14,042
Exercise of share options		12		215		–		–		227
Balance as of September 30, 2026		329		285,621		607		204,245		490,802
Balance as of January 1, 2025		377		362,507		(2,476)		170,446		530,854
Total comprehensive income for the period
Profit for the period		–		–		–		14,507		14,507
Other comprehensive income:
Foreign currency translation		–		–		2,949		–		2,949
Total comprehensive income for the period		–		–		2,949		14,507		17,456
Transactions with owners, recognized directly in equity
Own shares acquired		(53)		(90,006)		–		–		(90,059)
Share based compensation		–		12,228		–		–		12,228
Exercise of share options		8		435		–		–		443
Balance as of September 30, 2025		332		285,164		473		184,953		470,922

CONDENSED CONSOLIDATED INTERIM STATEMENTS OF CASH FLOWS (Unaudited)
		Nine months ended September 30
		2026			2025
		USD thousands
CASH FLOWS FROM OPERATING ACTIVITIES:
Profit for the period		8,756			14,507
Adjustments for:
Depreciation and amortization		51,442			46,868
Net financing income		(969)			(4,008)
Loss on leases modification		8			44
Share-based compensation and restricted shares		13,632			13,453
Tax expenses		4,031			8,768
Change in trade and other receivables		(31,043)			24,495
Change in trade and other payables		40,852			(23,945)
Change in employee benefits		5			(27)
Income taxes received		1,098			539
Income taxes paid		(2,258)			(10,226)
Interest received		2,204			3,505
Interest paid		(1,401)			(1,588)
Net cash provided by operating activities		86,357			72,385
CASH FLOWS FROM INVESTING ACTIVITIES
Change in pledged deposits, net		45			(89)
Payments on finance lease receivable		774			906
Acquisition of fixed assets		(20,819)			(9,327)
Repayment of debt investment		63			68
Investment in shares		(15,000)			(20,000)
Acquisition and capitalization of intangible assets		(15,548)			(12,866)
Net cash used in investing activities		(50,485)			(41,308)
CASH FLOWS FROM FINANCING ACTIVITIES
Acquisition of own shares		(7,301)			(90,853)
Proceeds from exercise of share options		227			443
Leases repayment		(11,594)			(12,349)
Net cash used in financing activities		(18,668)			(102,759)
Net increase (decrease) in cash and cash equivalents		17,204			(71,682)
CASH AND CASH EQUIVALENTS AS OF THE BEGINNING OF PERIOD		133,308			187,068
EFFECT OF EXCHANGE RATE ON CASH AND CASH EQUIVALENTS		2,399			1,342
CASH AND CASH EQUIVALENTS AS OF THE END OF PERIOD		152,911			116,728

• Registrational U.S. AURORA Phase 3 clinical trial underway for denifanstat in moderate to severe acne, with topline data anticipated in the second half of 2027
• Positive denifanstat Phase 3 clinical trial results in China from license partner Ascletis, and continued improvement and sustained efficacy across all efficacy endpoints through 52 weeks in the open-label extension clinical trial, presented at EADV 2026 and Fall Clinical Dermatology 2026
• Completed underwritten offering of Series A Common Stock and pre-funded warrants in October, with gross proceeds of $115 million
• Pro forma cash and investments balance of approximately $356 million as of September 30, expected to fund current operations through mid-2029 including through readout of data from the denifanstat AURORA Phase 3 clinical trial in moderate to severe acne and potential NDA submission​

FOSTER CITY, Calif., Nov. 12, 2026 (GLOBE NEWSWIRE) — Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing inhibitors of fatty acid synthase (FASN), a key lipid synthesis regulator, for acne, today reported financial results for the quarter ended September 30, 2026, and provided corporate updates.

“Building on the positive Phase 3 results from our license partner Ascletis, we have initiated our pivotal U.S. AURORA Phase 3 clinical trial,” said David Happel, Chief Executive Officer of Sagimet. “With our October equity financing, we are well positioned to fund our programs through mid-2029, including the anticipated Phase 3 denifanstat data readout and the potential submission of an NDA. If approved, denifanstat would be the first oral acne treatment with a novel mechanism of action approved by the FDA in more than 40 years, offering a new treatment option for approximately 10 million Americans living with moderate to severe acne.”

Recent Corporate Highlights

• AURORA Phase 3 clinical trial: In October 2026, Sagimet announced that the first patient had been dosed in its AURORA registrational U.S. Phase 3 clinical trial of once-daily denifanstat in adults and adolescents aged 12 years and older with moderate to severe acne. The Company plans to enroll approximately 800 patients in AURORA, including approximately 450 adolescents aged 12 to 17 years. The trial is intended to support a potential U.S. New Drug Application (NDA), with topline data expected in the second half of 2027.
• Equity financing: In October 2026, Sagimet completed an underwritten offering of Series A common stock and pre-funded warrants, resulting in approximately $115.0 million in gross proceeds, before deducting underwriting discounts and commissions and other offering expenses.
• TVB-3567: The single- and multiple-ascending dose and food effect parts of the first-in-human Phase 1 clinical trial of FASN inhibitor TVB-3567 completed dosing and TVB-3567 was generally well tolerated. Part D of the trial evaluating pharmacodynamic biomarkers in acne patients is ongoing. Phase 2 doses have been identified, and the Company anticipates initiating the Phase 2 clinical trial of TVB-3567 in moderate to severe acne patients before the end of 2026.
• KOL event: On September 30, 2026, Sagimet hosted a virtual key opinion leader (KOL) event featuring Julie Harper, MD, Founding Director and past President of the American Acne and Rosacea Society. During this event, the Company and Dr. Harper reviewed the 52-week data from license partner Ascletis’ Phase 3 open-label extension clinical trial of denifanstat in moderate to severe acne vulgaris in China and provided an update on Sagimet’s U.S. AURORA Phase 3 clinical trial of denifanstat for the treatment of moderate to severe acne (here).

Publications and Presentations

• EADV 2026: In September 2026, Sagimet announced positive full 52-week results from Ascletis’ Phase 3 open-label extension clinical trial of denifanstat in moderate to severe acne, which were presented by Ascletis at the European Academy of Dermatology and Venereology (EADV) Congress. Denifanstat showed progressive and sustained improvements across all efficacy endpoints in the open-label extension, including Investigator’s Global Assessment (IGA) success with a response rate of 57%, 72% reduction in total lesions, and 77% reduction in inflammatory lesions, and was generally well-tolerated, with no adverse event-related permanent discontinuations (here).
• Fall Clinical Dermatology 2026: In October 2026, Sagimet presented the positive 52-week results from Ascletis’ Phase 3 open-label extension trial, previously presented by Ascletis at EADV 2026, together with mechanistic data supporting denifanstat’s differentiated approach to targeting key aspects of acne pathogenesis: sebum production and inflammation (here).

Anticipated Upcoming Milestones

• Denifanstat: Continue enrollment in the U.S. AURORA Phase 3 clinical trial in moderate to severe acne, with topline data expected in the second half of 2027.
• TVB-3567: Initiate a Phase 2 trial in moderate to severe acne by year-end 2026.
• Topical FASN inhibitor: Continue development of a topical formulation of a FASN inhibitor for the potential treatment of acne.

Financial Results for the Three and Nine Months Ended September 30, 2026

• Cash, cash equivalents and marketable securities as of September 30, 2026, were $275.8 million, which included $27.5 million of investor funds received prior to the closing of the October 2026 underwritten offering of Series A common stock and pre-funded warrants. Pro forma cash, cash equivalents and marketable securities as of September 30 of $355.8 million, includes $80.0 million in additional net proceeds received on October 1 from the October 2026 underwritten offering.
• Research and development expense for the three and nine months ended September 30, 2026, was $16.3 million and $34.9 million, respectively, compared to $9.7 million and $32.3 million for the three and nine months ended September 30, 2025, respectively.
• General and administrative expense for the three and nine months ended September 30, 2026, was $5.2 million and $14.2 million, respectively, compared to $4.6 million and $13.8 million for the three and nine months ended September 30, 2025, respectively.
• Net loss for the three and nine months ended September 30, 2026, was $19.1 million and $43.8 million, respectively, compared to $12.9 million and $41.5 million for the three and nine months ended September 30, 2025, respectively.

About the AURORA Phase 3 Clinical Trial

AURORA (NCT07863193) is a multi-center, randomized, double-blind, placebo-controlled Phase 3 clinical trial of denifanstat in moderate to severe acne. AURORA is anticipated to enroll approximately 800 U.S. patients aged 12 years and older, of which 450 are expected to be adolescents aged 12 to 17 years. Patients will be randomized 2:1 to receive denifanstat 50 mg or placebo once daily for 12 weeks. The trial will have three co-primary endpoints that will be assessed at week 12: the proportion of patients achieving treatment success in a global assessment score, defined as at least a 2-point reduction from baseline with a score of 0 (clear) or 1 (almost clear); absolute change in inflammatory skin lesion counts from baseline; and absolute change in non-inflammatory skin lesion counts from baseline. A subset of approximately 530 patients completing the double-blind period will be eligible to enter a 40-week open-label extension evaluating the long-term safety of denifanstat.

About Denifanstat

Denifanstat is an oral, once-daily FASN inhibitor in development for the treatment of moderate to severe acne. In trials conducted by Sagimet’s license partner, Ascletis BioScience Co. Ltd. (Ascletis) in China, denifanstat met all primary and secondary endpoints in a 12-week randomized, double-blind Phase 3 clinical trial in moderate to severe acne vulgaris and was generally well-tolerated and showed improvements in all efficacy endpoints measured at 52 weeks (secondary endpoints of the trial) in an open-label extension clinical trial evaluating denifanstat’s long-term safety. Denifanstat is being developed by Ascletis as ASC40 for acne in China and by Sagimet in the rest of world.

About Acne

Acne is one of the most common skin conditions in the U.S., with approximately 50 million Americans affected annually and more than 6.8 million seeking medical treatment for acne each year. Acne affects around 85% of persons between the ages of 12 and 24. Moderate to severe acne accounts for 20% of acne sufferers, or approximately 10 million people in the U.S. annually. There is no cure for acne, and due to its pathology, most patients require chronic management and multiple annual courses of treatment for flare control.

About Sagimet Biosciences

Sagimet is a clinical-stage biopharmaceutical company advancing a portfolio of novel fatty acid synthase (FASN) inhibitors. FASN is a key regulator of the de novo lipogenesis pathway, which is overactive in acne and can cause elevated sebum and inflammation. FASN is also implicated in other diseases, including MASH and certain FASN-dependent tumor types. Denifanstat, Sagimet’s lead drug candidate, is an oral, once-daily FASN inhibitor currently being evaluated in a U.S. Phase 3 registrational clinical trial for moderate to severe acne. For more information, visit www.sagimet.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of, and made pursuant to the safe harbor provisions of, The Private Securities Litigation Reform Act of 1995. All statements contained in this press release, other than statements of historical facts or statements that relate to present facts or current conditions, including but not limited to, statements regarding the expected timing of the presentation of data from ongoing clinical trials, Sagimet’s clinical development plans and related timelines and anticipated development milestones, are forward-looking statements. These statements involve known and unknown risks, uncertainties and other important factors that may cause Sagimet’s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. In some cases, these statements can be identified by terms such as “may,” “might,” “will,” “should,” “expect,” “plan,” “aim,” “seek,” “anticipate,” “could,” “intend,” “target,” “project,” “contemplate,” “believe,” “estimate,” “predict,” “forecast,” “potential” or “continue” or the negative of these terms or other similar expressions. The forward-looking statements in this press release are only predictions. Sagimet has based these forward-looking statements largely on its current expectations and projections about future events and financial trends that Sagimet believes may affect its business, financial condition and results of operations. These forward-looking statements speak only as of the date of this press release and are subject to a number of risks, uncertainties and assumptions, some of which cannot be predicted or quantified and some of which are beyond Sagimet’s control, including, among others: the clinical development and therapeutic potential of denifanstat, TVB-3567 or any other drug candidates or combination therapies developed by Sagimet; Sagimet’s ability to advance drug candidates into and successfully complete clinical trials within anticipated timelines; Sagimet’s relationship with Ascletis, and the success of its development and registration efforts for denifanstat; the accuracy of Sagimet’s estimates regarding its capital requirements and Sagimet’s ability to maintain and successfully enforce adequate intellectual property protection. These and other risks and uncertainties are described more fully in the “Risk Factors” section of Sagimet’s most recent filings with the Securities and Exchange Commission and available at www.sec.gov. You should not rely on these forward-looking statements as predictions of future events. The events and circumstances reflected in these forward-looking statements may not be achieved or occur, and actual results could differ materially from those projected in the forward-looking statements. Moreover, Sagimet operates in a dynamic industry and economy. New risk factors and uncertainties may emerge from time to time, and it is not possible for management to predict all risk factors and uncertainties that Sagimet may face. Except as required by applicable law, Sagimet does not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise.

Investor Contact:
Joyce Allaire
LifeSci Advisors
JAllaire@LifeSciAdvisors.com

Media Contact:
Maggie Whitney
LifeSci Communications
mwhitney@lifescicomms.com

SAGIMET BIOSCIENCES INC. CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (unaudited) (in thousands, except for share and per share amounts)
	Three Months Ended September 30,								Nine Months Ended September 30,
	2026				2025				2026				2025
Operating expenses:
Research and development	$	16,340			$	9,730			$	34,870			$	32,320
General and administrative		5,227				4,604				14,228				13,804
Total operating expenses		21,567				14,334				49,098				46,124
Loss from operations		(21,567	)			(14,334	)			(49,098	)			(46,124	)
Total other income		2,418				1,426				5,346				4,654
Net loss	$	(19,149	)		$	(12,908	)		$	(43,752	)		$	(41,470	)
Net loss per share, basic and diluted	$	(0.31	)		$	(0.40	)		$	(0.88	)		$	(1.28	)
Weighted-average shares outstanding, basic and diluted		62,339,331				32,464,893				49,446,941				32,286,188
Net loss	$	(19,149	)		$	(12,908	)		$	(43,752	)		$	(41,470	)
Other comprehensive (loss) income:
Net unrealized (loss) gain on marketable securities		(483	)			41				(680	)			(113	)
Total comprehensive loss	$	(19,632	)		$	(12,867	)		$	(44,432	)		$	(41,583	)

SAGIMET BIOSCIENCES INC. CONDENSED BALANCE SHEETS (unaudited) (in thousands)
	As of
	September 30, 2026			December 31, 2025
Cash, cash equivalents and marketable securities	$	275,822		$	113,124
Total assets	$	282,093		$	116,482
Current liabilities	$	37,985		$	5,101
Noncurrent liabilities	$	1,927		$	–
Stockholders’ equity	$	242,181		$	111,381
Liabilities and stockholders’ equity	$	282,093		$	116,482

COLUMBUS, Ohio, Nov. 12, 2026 (GLOBE NEWSWIRE) — Bread Financial^® Holdings, Inc. (NYSE: BFH), a tech-forward financial services company that provides simple, personalized payment, lending, and saving solutions, today announced the company’s participation in the TD Cowen 2026 Financials & Fintech Conference Tuesday, November 17.

Bread Financial EVP and Chief Financial Officer Perry Beberman will participate in a fireside chat. The fireside chat will take place at 3:55 p.m. ET and will be broadcast live here.

The fireside chat can also be accessed through Bread Financial’s investor relations website. A replay of the webcast will be available for 90 days following the event.

About Bread Financial^®
Bread Financial^® (NYSE: BFH) is a tech-forward financial services company that provides simple, personalized payment, lending and saving solutions to millions of U.S. consumers. Our payment solutions deliver growth for some of the most recognized brands in travel & entertainment, health & beauty, technology, electronics, jewelry, home and specialty apparel through our co-brand and private label credit cards and pay-over-time products providing choice and value to our shared customers. Additionally, we offer Bread Financial general purpose credit cards and saving products that empower our customers and their passions for a better life.​ 

Bread Financial proudly marks 30 years of success in 2026. To learn more about our global associates, our performance and our sustainability progress, visit breadfinancial.com or follow us on Instagram and LinkedIn.

Contacts

Brian Vereb — Investor Relations
Brian.Vereb@breadfinancial.com

Susan Haugen — Investor Relations
Susan.Haugen@breadfinancial.com

Rachel Stultz — Media
Rachel.Stultz@breadfinancial.com  

• Trial with Nokia validates 800GbE service with an efficient 800GE client handoff over a single fiber pair
• Creates a simpler, more efficient way for customers to access high-capacity connectivity

LITTLE ROCK, Ark., Nov. 12, 2026 (GLOBE NEWSWIRE) — Uniti Wholesale, a leading provider of advanced fiber infrastructure solutions, today announced the successful trial of an industry first 800 Gigabit Ethernet (800GE) service delivered with a single fiber pair demarcation to the customer. The milestone demonstrates a simpler and more efficient way for customers to access 800G connectivity as demand for high-capacity network services continues to grow.

Conducted between Chicago, Ill., and Lexington, Ky., the trial demonstrated an 800GE service using the Nokia 1830 Global Express (GX) solution, establishing a single fiber 800G connectivity (IEEE 802.3dj 800GBASE-LR4). Unlike other available 800GE client interfaces that rely on multiple fiber pairs, the trial validates that Uniti can provide the complete 800G customer handoff over a single fiber pair.

The successful trial underscores Uniti’s continued investment in next-generation network capabilities and provides a foundation for delivering higher-capacity services through a customer interface designed to simplify access to 800G connectivity.

“Our customers are looking for more capacity, but they also want the experience of connecting to that capacity to be as simple and efficient as possible,” said Greg Ortyl, executive vice president and president of strategic accounts for Uniti Wholesale. “By demonstrating an 800G service with a single fiber pair handoff, we are simplifying the customer connection while giving businesses a straightforward path to the next generation of high-capacity connectivity. This industry-first achievement reflects our focus on making advanced network technology easier for our customers to access.”

“AI and cloud are driving unprecedented growth in data and creating demand for faster, more scalable connectivity across data centers, clouds and networks,” said Scott Cohen, senior vice president and North America Region leader at Nokia. “As capacity grows, the industry also needs simpler ways to access that bandwidth without adding operational complexity. Working with Uniti to demonstrate a single fiber 800G service is a great example of how optical innovation can increase network capacity into simpler, more efficient connectivity for customers.”

Uniti Wholesale expects to make the 800G service available to customers in the first quarter of 2027.

About Uniti Wholesale:
Uniti Wholesale, a business unit of Uniti (NASDAQ: UNIT), builds and delivers customer-driven dark fiber infrastructure and high-capacity wavelengths, ethernet and wireless access leveraging our optical transport network reaching nearly every hyperscale and AI firm, communications services provider, Fortune 500 enterprise and federal government customers in the U.S. and Canada. Additional information about Uniti Wholesale is available at unitiwholesale.com. Engage with us on LinkedIn.

FORWARD-LOOKING STATEMENTS
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on assumptions and management’s current expectations with respect to the future, involve certain risks and uncertainties, and are not guarantees. These forward-looking statements include, but are not limited to, statements regarding the anticipated availability of 800G service provided by Uniti Wholesale. The words “anticipates,” “believes,” “could,” “estimates,” “expects,” “intends,” “may,” “plans,” “projects,” “will,” “would,” “predicts” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Uniti may not actually achieve the plans, intentions or expectations disclosed in its forward-looking statements, and you should not place undue reliance on the forward-looking statements. Future results may differ materially from the plans, intentions and expectations disclosed in the forward-looking statements that Uniti makes. These forward-looking statements involve risks and uncertainties, known and unknown, that could cause events and results to differ materially from those in the forward-looking statements, including, without limitation: competition and overbuilding in consumer service areas and general competition in business markets; risks related to the Company’s indebtedness, which could reduce funds available for business purposes and operational flexibility; rapid changes in technology, which could affect its ability to compete; risks relating to information technology system failures, network disruptions, and failure to protect, loss of, or unauthorized access to, or release of, data; risks related to various forms of regulation from the Federal Communications Commission, state regulatory commissions and other government entities; effects of unfavorable legal proceedings, government investigations, and complex and changing laws; risks inherent in the communications industry and associated with general economic conditions; and additional risks set forth in the “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections of the Company’s most recently filed periodic reports on Form 10-K and Form 10-Q and subsequent filings with the U.S. Securities and Exchange Commission. The discussion of such risks is not an indication that any such risks have occurred at the time of this filing. Uniti does not assume any obligation to update any forward-looking statements.

Media Contact:
Scott Morris, 501-748-5342
scott.l.morris@uniti.com